Skip to main content

Cutler Group LP

SEC CIK
0001534270
Latest filing
Apr 19, 2024

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Cutler Group LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q1 2024 holdings

Shares (Q1 2024)
700
Value
$47.0K
% of portfolio
<0.1%
Quarters held
12
Since Q1 2021
Holdings of CRSP by Cutler Group LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 2024700$47.0K<0.1%+500+250.0%AddedHolders
Q4 2023200$12.0K<0.1%−1,800−90.0%ReducedHolders
Q3 20232,000$90.0K<0.1%−860−30.1%ReducedHolders
Q2 20232,860$160.0K<0.1%+2,160+308.6%AddedHolders
Q1 2023700$31.0K<0.1%+700NewHolders
Q4 20220$00.0%−12,553−100.0%Sold outHolders
Q3 202212,553$820.0K0.1%−247−1.9%ReducedHolders
Q2 202212,800$777.0K0.1%−10,668−45.5%ReducedHolders
Q1 202223,468$1.47M0.1%+730+3.2%AddedHolders
Q4 202122,738$1.72M0.1%+9,838+76.3%AddedHolders
Q3 202112,900$1.44M0.1%+2,320+21.9%AddedHolders
Q2 202110,580$1.71M0.1%+2,580+32.3%AddedHolders
Q1 20218,000$974.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.